Connect with us
Trulieve’s NYSE listing marks a milestone for the cannabis industry, giving a major US producer access to institutional capital after years of restrictions. The move may...
The DEA has begun a key hearing on reclassifying cannabis from Schedule I to Schedule III, following a recommendation from health authorities. While not legalization, the...
WNBA removed cannabis from its banned substances list in a new CBA running 2026–2032, aligning with NBA policy and allowing players to invest in the cannabis...
EUDA report shows cannabis remains Europe’s most used illegal drug, with 22 million adults trying it. Use is highest among 15–34-year-olds, especially men, and daily consumption...
Germany’s cannabis legalization has reduced criminal cases and eased pressure on the justice system, while the black market is slowly declining. Cannabis clubs lag behind expectations...
Cannabis seeds purchase becomes legal in Argentina under INASE Resolution 260/2022, allowing open acquisition but keeping cultivation illegal without Reprocann registration. Only registered seeds and seedlings...
Medical cannabis use in England continues to grow, with prescriptions exceeding 633,000 items by 2025. While cannabis flower remains the most common format, it is no...
The international cannabis industry is shifting, with North America facing pricing and regulatory challenges while Europe, especially medical cannabis, becomes a key growth region. Tilray Brands...
Europe’s medical cannabis market has expanded rapidly through telemedicine, e-prescriptions, and mail-order pharmacies, especially in Germany. This growth has improved patient access but raised political concerns...
Germany’s medical cannabis market is expanding, with over 50 tons imported in early 2026, making it Europe’s leading market. Reforms improved patient access and boosted demand,...